BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3452664)

  • 1. [Significance of coagulase negative staphylococci on skin-relation to cutaneous infection by Staphylococcus aureus: experimental animal infection].
    Ikeda M
    Nihon Hifuka Gakkai Zasshi; 1987 Dec; 97(14):1631-43. PubMed ID: 3452664
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody studies in a rabbit model of corneal phlyctenulosis and catarrhal infiltrates related to Staphylococcus aureus.
    Mondino BJ; Adamu SA; Pitchekian-Halabi H
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1854-63. PubMed ID: 2032807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different susceptibility of coagulase-positive and coagulase-negative staphylococci to ciprofloxacin.
    Utili R; Tripodi MF; Rosario P; Andreana A; Locatelli A; Rambaldi A; Florio A
    New Microbiol; 1996 Oct; 19(4):309-14. PubMed ID: 8914131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reduced phagocytosis in immunized animals].
    Pal'tsyn AA; Kolokol'chikova EG; Badikova AK; Chervonskaia NV; Grishina IA
    Biull Eksp Biol Med; 1996 Sep; 122(9):348-52. PubMed ID: 8974498
    [No Abstract]   [Full Text] [Related]  

  • 5. [Infections caused by staphylococci. The human as a source of infection for S. aureus and coagulase negative staphylococci].
    Peters G
    Fortschr Med; 1991 Jul; 109(22):437-40. PubMed ID: 1937322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal humoral immune response to Staphylococcus aureus in patients with Staphylococcus aureus hyper IgE syndrome.
    Matter L; Wilhelm JA; Roth F; Schopfer K
    Clin Exp Immunol; 1986 Nov; 66(2):450-6. PubMed ID: 3815899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunosuppressive effect of cyclophosphamide in experimental coagulase-negative staphylococcal infection].
    Nagy G; Pappné FE; Kovács P; Sztroj T; Rozgonyi F
    Orv Hetil; 1993 May; 134(20):1077-81. PubMed ID: 8497387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulase-negative staphylococci--saphrophyte or parasite?
    Christensen GD
    Int J Dermatol; 1983 Oct; 22(8):463-5. PubMed ID: 6642831
    [No Abstract]   [Full Text] [Related]  

  • 9. Protective effect in the lactating bovine mammary gland induced by coagulase-negative staphylococci against experimental Staphylococcus aureus infections.
    Poutrel B; Lerondelle C
    Ann Rech Vet; 1980; 11(4):327-32. PubMed ID: 7337390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-phase radioimmunoassay for IgG antibodies to Staphylococcus epidermidis. Use in serious coagulase-negative staphylococcal infections.
    Espersen F; Wheat LJ; Bemis AT; White A; Bayer AS; Hooper DC
    Arch Intern Med; 1987 Apr; 147(4):689-93. PubMed ID: 3103563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of humoral immunity and acute inflammation in protection against staphyloccocal dermonecrosis.
    Easmon CS; Glynn AA
    Immunology; 1975 Jul; 29(1):67-74. PubMed ID: 124702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of abrasion of teat orifice epithelium on development of bovine staphylococcal mastitis.
    Myllys V; Honkanen-Buzalski T; Virtanen H; Pyörälä S; Müller HP
    J Dairy Sci; 1994 Feb; 77(2):446-52. PubMed ID: 8182169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylococcus epidermidis endocarditis and Staphylococcus epidermidis infection in an intensive care unit.
    Verhoef J; Fleer A
    Scand J Infect Dis Suppl; 1983; 41():56-64. PubMed ID: 6589762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for skin carriage of methicillin-resistant coagulase-positive staphylococci and Staphylococcus schleiferi in dogs with healthy and inflamed skin.
    Griffeth GC; Morris DO; Abraham JL; Shofer FS; Rankin SC
    Vet Dermatol; 2008 Jun; 19(3):142-9. PubMed ID: 18477330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coagulase-negative staphylococci in normal and chronically inflamed conjunctiva].
    Grasbon T; Miño de Kaspar H; Klauss V
    Ophthalmologe; 1995 Dec; 92(6):793-801. PubMed ID: 8563427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neutralizing effects of hyperimmune antibodies against extracellular fibrinogen-binding protein, Efb, from Staphylococcus aureus.
    Shannon O; Uekotter A; Flock JI
    Scand J Immunol; 2006 Mar; 63(3):184-90. PubMed ID: 16499571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid resistance in coagulase-negative staphylococci.
    Kelly S; Collins J; Davin M; Gowing C; Murphy PG
    J Antimicrob Chemother; 2006 Oct; 58(4):898-9; author reply 899-900. PubMed ID: 16854956
    [No Abstract]   [Full Text] [Related]  

  • 18. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant.
    Josefsson E; Hartford O; O'Brien L; Patti JM; Foster T
    J Infect Dis; 2001 Dec; 184(12):1572-80. PubMed ID: 11740733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of the increased resistance of mice to Pseudomonas aeruginosa caused by Staphylococcus aureus].
    Mathieu LG; deRepentigny J; Gadbois T
    Can J Microbiol; 1976 Dec; 22(12):1734-42. PubMed ID: 827329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biological properties and cross-reacting antigens of staphylococcus in allergic vasculitis].
    Shaposhnikov OK; Domaseva TV; Anatoliĭ SA; Stogov IuN
    Vestn Dermatol Venerol; 1986; (6):4-8. PubMed ID: 3751275
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.